ArticleRheumatology advances in practice2025
Comment on: Longitudinal risk of serious infections in patients with inflammatory arthritis on immunomodulating therapy compared to controls.
Rebecca ParryPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.